Viewing StudyNCT00478777



Ignite Creation Date: 2024-05-05 @ 5:30 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00478777
Status: COMPLETED
Last Update Posted: 2011-11-03
First Post: 2007-05-23

Brief Title: A Multicenter Single-Arm Open-Label Expanded Access Program for Lenalidomide Plus Dexamethasone in Previously Treated Subjects With Multiple Myeloma
Sponsor: Celgene Corporation
Organization: Celgene

Conditions & Keywords Data

Conditions:
Name
Relapsed or Refractory Multiple Myeloma
Keywords:
Name View
Multiple Myeloma View
CC-5013 View
Revlimid View
Lenalidomide View
Celgene View